Which is the India's Best Highway Infrastructure company?
The Ministry of Road Transport and Highways in India stands as the proud custodian of what is hailed as "India's Exemplary Highway Network." Often referred to as National Highways, these thoroughfares boast outstanding infrastructure and contemporary attributes. Their design frequently incorporates flyovers for controlled access, ensuring seamless entry and exit from their sides. To alleviate traffic congestion within cities, towns, and villages, these highways feature flyovers at intersections and maintain a top speed limit of 100 km/h.
The sprawling expanse of India's Exemplary Highway Network encompasses interchanges in certain sections, though not all segments are entirely regulated for access. Collaborative efforts between the National Highways and Infrastructure Development Corporation Limited (NHIDCL), the Central Public Works Department (CPWD), and state governments' public works departments (PWD) are dedicated to the construction and maintenance of these routes. Currently, National Highway 44 holds the distinction of being India's longest national highway, stretching over 4,112 kilometers (2,555 miles).
The National Highways Development Project (NHDP), meticulously overseen by the Ministry of Road Transport and Highways, plays an instrumental role in modernizing and expanding India's road network, fueling the nation's progress.
Specifically focusing on the expansion of a 124.52 km segment of NH 2 in Uttar Pradesh from four lanes to six lanes, the India's Best Highway Infrastructure Bypass NH 2 Project follows a build-operate-transfer (BOT) or design-build-finance-operate-transfer (DBFOT) framework.
Prominent features of the project comprise:
- A six-lane highway spanning 124.52 kilometers.
- An aggregate lane extension totaling 750 kilometers.
- A roadway stretch spanning 84.725 kilometers.
- Slip road span encompassing 30.282 kilometers.
- Inclusion of three significant bridges.
- Incorporation of thirty smaller spans.
- Integration of seven overhead structures.
- Establishment of seven railway overpasses.
- Implementation of noise barriers spanning 3.08 kilometers.
- Installation of streetlights covering a distance of 44.68 kilometers.
The anticipated project expenditure amounts to Rs. 3,244 Crores, underpinning the concession duration of 24 years.
Unveiling the Corridor:
The bustling National Highway 2 traverses several Indian states, weaving its way through Delhi, Haryana, Uttar Pradesh, Bihar, Jharkhand, and West Bengal. It is commonly recognized as the Delhi-Kolkata Road.
Among the illustrious projects that the National Highways Authority of India (NHAI) has undertaken, the Agra Etawah Bypass NH 2 Project shines as a testament to its prestigious and ambitious initiatives.
Agra, Firozabad, Mainpuri, and Etawah are among the districts in Uttar Pradesh that the proposed route graces. The towns of Agra, Etmadpur, Firozabad, Shikohabad, Jaswantnagar, and Etawah stand as prominent landmarks along this route. These locales boast cultural and historical treasures, including the Taj Mahal, Fatehpur Sikri, and Red Fort, drawing visitors from across the globe. The Bharatpur National Park's avian sanctuary holds the honor of being a designated World Heritage Site. Additionally, the mausoleums of Itmad-ud-Daula and Akbar in Sikandara have been proposed as potential future World Heritage Sites.
What are the fine capabilities of Agra Etawah Toll Road Project
The Agra Etawah Toll Road Project serves as a prime exemplar of the critical role national highways play in facilitating seamless interstate movement of passengers and freight. These expansive road networks span the length and breadth of the nation, connecting federal and state government capitals, vital ports, railway junctions, border passages, and international thoroughfares.
Modern Road Makers' mission revolves around providing exceptional roadway infrastructure that meets stringent quality standards. These amenities encompass supplementary lanes, enhanced road surfaces, dedicated lanes, intersection-grade separations, protective barriers, and more. The highways conceived as part of the Agra Etawah Toll Road Project are meticulously designed to accommodate through traffic and ensure the swift passage of vehicles. The ownership of these highways can be divided between the Central Government and respective State Governments, depending on their classification as either National Highways or State Roads.
The collaboration between the National Highways Authority of India (NHAI) and AE Tollway Private Limited (AETPL), an SPV (special purpose vehicle) under IRB Infrastructure Developers Ltd., culminated in a concession agreement on September 1st, 2015. This agreement entails the construction, operation, and maintenance of the Agra Etawah Bypass NH 2 Project. For a duration of 24 years, post the specified timeline, the project remains under concession. During this period, the concessionaire has the authorization to levy the prescribed user fee on drivers.
The segment between Agra and Etawah, spanning 124.52 km along NH 2, forms an integral part of the Agra Etawah Bypass NH 2 Project. Through a build-operate-transfer (BOT) or design-build-finance-operate-transfer (DBFOT) framework, this stretch will be expanded from four to six lanes.
Key highlights of the project include:
- Development of a six-lane highway covering 124.52 kilometers.
- A cumulative lane length of 750 kilometers.
- Roadway extension of 84.725 kilometers.
- Slip road span of 30.282 kilometers.
- Construction of three major bridges.
- Integration of thirty minor spans.
- Inclusion of seven overhead structures.
- Implementation of seven railway overpasses.
- Incorporation of noise barriers spanning 3.08 kilometers.
- Installation of streetlights along 44.68 kilometers.
- The project spans a concession period of 24 years and involves an investment of Rs. 3,244 Crores.
Describing the Corridor:
The bustling National Highway 2 traverses multiple Indian states, encompassing Delhi, Haryana, Uttar Pradesh, Bihar, Jharkhand, and West Bengal. It is also commonly referred to as the Delhi-Kolkata Road.
The Agra Etawah Bypass NH 2 Project stands as a testament to NHAI's significant endeavors in advancing crucial infrastructure initiatives.
This proposed highway route traverses Uttar Pradesh districts such as Agra, Firozabad, Mainpuri, and Etawah. Among the notable towns along the route are Agra, Etmadpur, Firozabad, Shikohabad, Jaswantnagar, and Etawah.
Agra, renowned for the iconic Taj Mahal, Fatehpur Sikri, and Red Fort, stands as a globally acclaimed travel destination. Furthermore, the Bharatpur National Park's avian sanctuary has earned recognition as a World Heritage Site. The Sikandara mausoleums of Itmad-ud-Daula and Akbar also hold the potential to be designated as future World Heritage Sites.
ControlWorks is a Tridium Niagara controls partner Tridium is a leading provider of building automation solutions that help optimise building energy consumption. In addition to the Niagara 4 Framework, our partnership with Tridium allows us to offer our clients a wide range of other building automation solutions, including:
https://www.controlworks.com.a....u/partners/tridium-n
Reveal your natural beauty with Skinsational Scents' gentle natural soap for the face. Our skincare secret lies in botanical ingredients that cleanse, nourish, and rejuvenate. Experience the purest way to enhance your complexion. Explore our collection and embrace a healthier, glowing visage. Elevate your skincare routine with our exquisite face soap. Discover the difference today.
https://www.skinsationalscents.....com/body-care/handc
On-Demand Service App | Uber for X | Get the Best Clone App
On demand app development Company. We provide ready to use Uber for x script for all startup businesses - taxi, food, grocery, massage, and beauty services.
Visit our website for more information: https://whitelabelfox.app/
#ondemandserviceapp #ondemandappdevelopmentcompany #uberforx #uberforxscripts #taxiservices #deliveryplatforms #fooddelivery #doctorappointmentscheduling #beautyservices #plumbingservices #homecleaningservices #gojekcloneapp
Discover headache solutions at Family Dental Solutions. Our experienced team specializes in addressing dental-related headaches, providing effective treatments to relieve discomfort and improve your quality of life. Say goodbye to headaches and hello to lasting relief. Schedule your consultation today for personalized care and effective solutions.
https://familydentalsolutions.com/our-services
Bispecific Antibodies market Size, Share, Trends by 2035
Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder
Roots Analysis has announced the addition of “Bispecific Antibodies Market, 2023-2035” report to its list of offerings.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the market for such therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
An executive summary of the key insights captured during our research
A brief introduction to bispecific antibodies, highlighting their historical background, as well as information on their structure, different types available, unique antibody formats, mechanisms of action of various drugs and their applications
A detailed review of the market landscape of over 220 bispecific antibodies that are either approved or being evaluated in different stages of clinical development
An in-depth assessment of the market landscape of over 180 bispecific antibodies that are currently being evaluated in preclinical studies
An insightful analysis, highlighting the contemporary market trends in the bispecific antibody therapeutics domain, through six different graphical representations
A detailed assessment of over 80 technology platforms being developed / used by various drug developers for the production of bispecific antibody therapeutics
An in-depth analysis of big pharma players engaged in this domain, featuring insightful spider web analyses and heat map analyses
Elaborate profiles of prominent drug developers engaged in the development of bispecific antibodies, featuring a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key members of the executive team, financial details / information (if available), drug portfolio, recent developments and an informed future outlook
An insightful analysis of various partnerships inked between stakeholders engaged within the bispecific antibody therapeutics domain, during the period 2016-2023
A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies, along with information on various contract manufacturing organizations (CMOs) and contract research organizations (CROs) engaged in this domain
An in-depth analysis of ongoing and planned clinical trial studies related to bispecific antibody therapeutics, which were registered till April 2023
A review of regulatory guidelines issued by the ICH, WHO and FDA for the development of bispecific antibodies. In addition, it provides details related to the responses of various pharmaceutical industries to the FDA guidelines
A review of different channels used for promoting marketed bispecific antibodies, elaborating on the various promotional strategies being adopted by developers of two approved bispecific antibodies (chosen based on their popularity in this domain), namely Blincyto™ and Hemlibra®
A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework, featuring a qualitative Harvey ball analysis highlighting the relative impact of each SWOT parameter on the overall market
A comprehensive market forecast analysis, including future sales projections of bispecific antibodies that are either marketed or under phase III of clinical development, till the year 2035, presenting a detailed market segmentation on various segments:
Therapeutic Area
Autoimmune Disorders
Genetic Disorders
Hematological Malignancies
Ophthalmic Disorders
Skin Cancers
Solid Tumors
Mechanism of Action
Cytokines Retargeting / Neutralization
Dual Ligands Blocking
Resistance Factors Co-targeting
Targeting Tumor Angiogenesis
T-Cell Retargeting / Activation
Others
Target Antigen
C5-Albumin
CD20 x CD3
CD3 x BCMA
CD3 x CD19
EGFR x cMET
EpCAM x CD3
Factor IXa x Factor X
gp100 x CD3
HER2 x HER2
PD-1 x CTLA-4
PD-L1 x TGFβ
TNF-α x HSA
VEGF x DLL4
VEGF-A x ANG2
Antibody Format
Asymmetric
Fragments
Key Players
Akeso Biopharma
Alexion
Amgen
Genmab
Immunocore
Janssen Research & Development
Linton Pharm
Merck
OncXerna Therapeutics
Pfizer
Roche
Taisho Pharmaceutical
Zymeworks
Key Geographical Regions
Asia
Europe
North America
Rest of the World
Key companies covered in the report
Akeso Biopharma
Alphamab Oncology
Amgen
Merck
Regeneron
Roche
Xencor
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen
Learn from experts: do you know about these emerging industry trends?
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services
Top 10 Quantum Computing Companies Transforming Drug Discovery
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#bispecificantibodiesmarket #bispecificantibodiesmarketsize #bispecificantibody #bispecificantibodies #approvedbispecificantibodies